488 related articles for article (PubMed ID: 33500648)
1. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
[TBL] [Abstract][Full Text] [Related]
2. Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer.
Ying HQ; Chen W; Xiong CF; Wang Y; Li XJ; Cheng XX
Cancer Cell Int; 2022 Mar; 22(1):137. PubMed ID: 35346200
[TBL] [Abstract][Full Text] [Related]
3. Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC.
Ying HQ; Liao YC; Luo YR; Xiong G; Huang Y; Nie RW; Xiong CF; Cheng XX
Pharmacol Res; 2021 Aug; 170():105734. PubMed ID: 34157424
[TBL] [Abstract][Full Text] [Related]
4. Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II-III colorectal cancer patients.
Sun F; Peng HX; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Wang XZ; Ying HQ
Cancer Manag Res; 2018; 10():2151-2161. PubMed ID: 30050325
[TBL] [Abstract][Full Text] [Related]
5. High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients.
Ying HQ; You XH; Liao YC; Sun F; Cheng XX
Front Oncol; 2021; 11():580455. PubMed ID: 33968712
[No Abstract] [Full Text] [Related]
6. Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I-III Mucinous Colorectal Adenocarcinoma.
Liao YC; Ying HQ; Huang Y; Luo YR; Xiong CF; Nie RW; Li XJ; Cheng XX
Cancer Manag Res; 2021; 13():3455-3464. PubMed ID: 33907468
[TBL] [Abstract][Full Text] [Related]
7. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.
Du JH; Lu J
J Clin Lab Anal; 2019 Feb; 33(2):e22684. PubMed ID: 30461064
[TBL] [Abstract][Full Text] [Related]
8. Systemic Immune-Inflammation Index Predicts Tumor Recurrence after Radical Resection for Colorectal Cancer.
Nakamoto S; Ohtani Y; Sakamoto I; Hosoda A; Ihara A; Naitoh T
Tohoku J Exp Med; 2023 Nov; 261(3):229-238. PubMed ID: 37673651
[TBL] [Abstract][Full Text] [Related]
9. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer.
Ying HQ; Sun F; Liao YC; Cai D; Yang Y; Cheng XX
Ther Adv Med Oncol; 2021; 13():17588359211022886. PubMed ID: 34262615
[TBL] [Abstract][Full Text] [Related]
10. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
11. Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma.
Zhao X; Zhou Y; Liu B; Shen Y; Qian J; Zhang X; Zhao H
Med Sci Monit; 2023 Mar; 29():e939442. PubMed ID: 36992543
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
13. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-based Indexes Upon Adjuvant Chemotherapy Initiation as a Predictor of Relapse After Curative Resection of Colorectal Cancer With an Oxaliplatin-based Regimen.
Satake M; Yoshimatsu K; Sagawa M; Yokomizo H; Shiozawa S
Cancer Diagn Progn; 2022; 2(1):64-70. PubMed ID: 35400004
[TBL] [Abstract][Full Text] [Related]
15. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
16. Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma.
Huang H; Chen LM; Fang XJ; Guo CC; Lin XP; Hong HM; Li X; Wang Z; Tian Y; Chen MT; Yao YY; Chen Z; Li XQ; Pan F
Front Pharmacol; 2020; 11():593392. PubMed ID: 33101044
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer.
Zhang J; Li SQ; Liao ZH; Jiang YH; Chen QG; Huang B; Liu J; Xu YM; Lin J; Ying HQ; Wang XZ
Oncotarget; 2017 Sep; 8(43):75195-75205. PubMed ID: 29088857
[TBL] [Abstract][Full Text] [Related]
18. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Combined LMR and CEA Dynamic Monitoring in Postoperative Colorectal Cancer Patients.
Chen S; Zhang J; Qian C; Qi X; Mao Y; Lu T
J Inflamm Res; 2023; 16():4229-4250. PubMed ID: 37772275
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
